When broken down by state, most of the country is experiencing elevated respiratory illness, including a few states with ...

Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday.

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

MODERNA cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

While a seasonal uptick in respiratory viruses is expected in winter each year, we’re still seeing higher overall numbers ...

Chances are someone in your life has been sick over the past couple of weeks as respiratory illnesses, like the flu and ...

Respiratory virus activity across the nation remains high, with COVID-19 levels rising across much of the country, flu ...

The US Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information for the Abrysvo (Pfizer) and Arexvy (GlaxoSmithKline) respiratory syncytial ...

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter.

In the Lehigh Valley, cases of the flu and RSV are particularly prevalent compared with many other parts of the state.

Six states reported "very high" levels of respiratory illness activity: Arizona, Oklahoma, Kentucky, New Hampshire, Delaware and Hawaii. Here are five more updates from the CDC report: Emergency ...

As of January 4th, MDHHS reported that 6.6% of emergency room visits and nearly 13.8% of hospitalizations per 100,000 people ...